Atossa Therapeutics
ATOS
#10646
Rank
ยฃ18.57 M
Marketcap
ยฃ1.86
Share price
-1.93%
Change (1 day)
230.96%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -ยฃ27.97 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ25.49 Million a decrease over its 2024 earnings that were of -ยฃ18.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ27.97 Million9.72%
2025 -ยฃ25.49 Million36.33%
2024 -ยฃ18.7 Million-15.25%
2023 -ยฃ22.06 Million11.62%
2022 -ยฃ19.77 Million30.84%
2021 -ยฃ15.11 Million15.58%
2020 -ยฃ13.07 Million3.41%
2019 -ยฃ12.64 Million51.16%
2018 -ยฃ8.36 Million40.41%
2017 -ยฃ5.96 Million27.54%
2016 -ยฃ4.67 Million-47.49%
2015 -ยฃ8.89 Million-17.25%
2014 -ยฃ10.75 Million35.91%
2013 -ยฃ7.91 Million112.3%
2012 -ยฃ3.73 Million46.53%
2011 -ยฃ2.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.04 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ1.00 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ1.00 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ30.54 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ72.9 Million 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.75 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA